Can’t blame Jeff for building up HGH’s institutional shareholder base at the expense of small retail shareholders.
Realistically, the institutions are the ones who can pour the hundreds of millions or billions of dollars required to fund growth if he gets the strategy right.
So has he got the strategy right?
Is expansion into Australia really a good idea?